FDA Delivers OTC Monograph Facility Fees For Fiscal 2024 With Highlights On Some RSVPs

FDA “is highlighting” in its FY2024 facility fees announcement, and using italics for “emphasis added” for some statements, that businesses previously but no longer making hand sanitizers, though still selling the products, should contact the agency to assure they’re not assessed fees.